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Abstract
Purpose Physical activity can improve health of cancer survi-
vors. To increase physical activity levels among colorectal
cancer (CRC) survivors, we need to understand which factors
affect physical activity. Therefore, this study examined
the longitudinal relationship between symptom-related,
functioning-related, and psychological barriers and socio-
demographic and clinical factors with physical activity among
CRC survivors.
Methods CRC survivors identified from the population-based
Eindhoven Cancer Registry (ECR) diagnosed between 2000
and 2009 were included. Survivors completed validated ques-
tionnaires measuring moderate-to-vigorous physical activity
(MVPA) and barriers in 2010(T1), 2011(T2), and 2012(T3).
Linear-mixed models and linear regression techniques were
used.
Results Response rates were 74 % (N=2451, T1); 47 % (N=
1547, T2); and 41 % (N=1375, T3). Several factors were
negatively associated with MVPA: symptom-related barriers
(e.g., fatigue, dyspnea, chemotherapy side effects, pain, appe-
tite loss, and weight loss); psychological barriers (i.e., depres-
sive symptoms and anxiety); functioning-related barriers (e.g.,
low physical or role functioning, unfavorable future
perspective); socio-demographic (i.e., older age, female, no
partner); and clinical factors (i.e., obesity). However, no
within-subject effects were significantly associated with
MVPA. Groups of functioning-related barriers, socio-
demographic factors, symptom-related barriers, psychological
barriers, and clinical factors explained 11, 3.9, 3.8, 2.4, and
2.2 % of the variance in MVPA at T1, respectively.
Conclusions Several functioning-related and symptom-
related barriers and few socio-demographic factors were asso-
ciated with physical activity among CRC survivors. Future
interventions to promote physical activity among CRC survi-
vors could benefit by taking into account functioning aspects
and symptoms of cancer and its treatment, and assess the
causal direction of these associations.
Keywords Colorectal cancer . Cancer survivorship . Physical
activity . Exercise . Population based . Longitudinal study
Introduction
Colorectal cancer (CRC) is one of the leading causes of death
worldwide and the third most common cancer type in the
Netherlands, with 13,300 new cases diagnosed in 2013 [1].
Physical activity is important for CRC survivors because it
decreases the risk of recurrence and comorbidities and has
beneficial effects on certain health-related quality of life
(HRQoL) domains [2–6]. However, less than one third of
the CRC survivors comply with the physical activity guide-
lines (>2.5 h/week moderate-to-vigorous physical activity
(MVPA)) [3, 7].
Many social cognitive models of human behavior, includ-
ing the widely used Theory of Planned Behavior and Health
Belief Model (HBM) [8, 9], contain constructs related to be-
havior change barriers. The HBM identifies Bperceived
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barriers,^ which refer to the patient’s assessment of ob-
stacles to change physical activity. These perceived bar-
riers may act as obstacles to undertake the recommended
level of physical activity and could be classified into
symptom-related barriers (e.g., fatigue, diarrhea, nausea,
and having a stoma) [10–13]; functioning-related barriers
(e.g., physical and social functioning) [14]; and psycho-
logical barriers (e.g., anxiety and depressive symptoms)
(Table 1) [8, 10–13, 15]. Furthermore, physical activity
behavior could also be affected by socio-demographic
and clinical factors. For instance, studies show that
CRC survivors who were younger, male, have a partner,
a lower BMI, who were diagnosed with colon cancer,
treated with chemotherapy, with a longer time since di-
agnosis and no comorbidities were more physically ac-
tive [10, 12].
Nevertheless, previous studies had low response rates
or cross-sectional designs, highlighting the need for
larger studies and longitudinal designs. Longitudinal
analysis allows to examine the relationship between bar-
riers and MVPA levels over time. Hence, a longitudinal
study has the potential to inform future intervention de-
velopment to increase physical activity by understanding
what barriers of change need to be targeted in a grow-
ing proportion of people surviving CRC. Although a
longitudinal study is insufficient to distinguish true cau-
sality, it aids studying causal associations.
Therefore, the aims of the current study were to examine
(1) the longitudinal relationship between symptom-related,
functioning-related, and psychological barriers and socio-
demographic and clinical factors with physical activity among
CRC survivors and (2) which group of factors contained the
largest barriers of physical activity. Besides the individual
associations between aforementioned barriers and MVPA, it
seems plausible that some barriers are related with each other
and together influenceMVPA [10–13]. In this study, effects of
groups of barriers are defined as Bconjoint effects.^ Examin-
ing the conjoint effects of symptom-related, functioning-relat-
ed, and psychological barriers and socio-demographic and
clinical factors on physical activity could be used to investi-
gate which group of factors contains the largest barriers for
survivors.
We hypothesized that the following factors are nega-
tively associated with physical activity: symptom-related
barriers (e.g., fatigue, dyspnea, stoma-related problems,
nausea, insomnia, chemotherapy side effects, pain, appe-
tite loss, micturition problems, gastro-intestinal problems,
defecation problems, weight loss, and financial prob-
lems); psychological barriers (i.e., depressive symptoms
and anxiety); functioning-related barriers (e.g., low phys-
ical role; social, emotional, and cognitive functioning;
unfavorable future perspective, body image and a low
global quality of life).
Methods
Setting and participants
A longitudinal population-based cohort study was performed
among CRC survivors registered within the Eindhoven Can-
cer Registry (ECR) of the Comprehensive Cancer Centre,
The Netherlands. The ECR records data on all newly diag-
nosed cancer patients in the Southern part of the Netherlands,
Table 1 Classification of possible factors associated with physical












































Body mass index (BMI)
Support Care Cancer
an area with 2.4 million inhabitants, ten hospital locations, and
two large radiotherapy institutes. Individuals diagnosed be-
tween 2000 and 2009 with colon or rectal cancer stage I–III
(N=3323) as registered in the ECR, were eligible for partici-
pation (see flowchart: http://www.profilesregistry.nl/
dataarchive/study_units/view/22). CRC survivors with stage
IV were excluded (N=114) from the analyses to obtain a more
homogeneous study population. This study was approved by
the local Medical Ethics committee of the Maxima Medical
Centre. All included participants signed an informed consent.
Data collection
Data collection took place in December 2010 (T1), 2011 (T2),
and 2012 (T3) by using questionnaires. Survivors received a
letter from their (ex-) attending specialist to inform them about
the study. Data collection was done within Patient Reported
Outcomes Following Initial treatment and Long term Evalua-
tion of Survivorship (PROFILES). PROFILES is a registry for
the study of the physical and psychosocial impact of cancer
and its treatment from a dynamic, growing population-based
cohort of both short- and long-term cancer survivors. PRO-
FILES contains a large web-based component and is linked
directly to clinical data from the ECR [16].
Measures
Physical activity was assessed with the European Prospective
Investigation into Cancer (EPIC) Physical Activity Question-
naire [17]. Participants were asked how many hours per week
they spent on average on walking, bicycling, gardening,
housekeeping, and sports in summer and winter. Six sports
could be reported. First, the mean duration spent on these
activities in summer and winter were computed. Second, to
include an estimate of intensity, metabolic equivalent intensity
values (1 MET=4.184 kJ/kg body weight/h) were assigned to
each activity, according to the compendium of physical activ-
ities [18, 19]. Finally, the duration of moderate-to-vigorous
physical activity (MVPA) was assessed as time (h/week) spent
on walking, bicycling, gardening and sports (≥3 MET).
Housekeeping and light intensity sports were excluded from
calculating the duration of MVPA [18, 19].
Clinical information was obtained from the ECR (i.e., gen-
der, date of birth, years since diagnosis, localization of cancer,
tumor stage, and primary treatment). Other relevant socio-
demographic and clinical factors were obtained via questions
concerning marital status/partner and educational level. Fur-
thermore, comorbidity in the last 12months was assessed with
the Self-administered Comorbidity Questionnaire (SCQ) [20].
Anxiety and depressive symptoms were assessed with the
Hospital Anxiety and Depression Scale (HADS) [21]. The
questionnaire consist of 14 items which can be answered on
a 4-point scale. The HADS yields separate scale scores for
anxiety and depressive symptoms. The total score for
each scale can range from 0 to 21. Cut-off values for
anxiety or depressive symptoms were indicated by a
score of ≥8. [21, 22].
Participants’ functioning and symptoms were assessed
with the European Organization for Research and Treatment
of Cancer (EORTC) Quality of Life Questionnaire (QLQ)-
C30 [23]. This questionnaire consists of 30 items and ques-
tions can be answered on a 4-point scale. The following scales
were included in the analysis: physical, social, emotional, cog-
nitive, and role functioning scales; global quality of life scale;
pain and nausea scales; and the single items dyspnea, insom-
nia, appetite loss, and financial problems.
Fatigue was measured with the Fatigue Assessment Scale
(FAS) [24]. The questionnaire consists of 10 items which can
be answered on a 5-point scale. The total score can range from
10 to 50. Cut-off values for fatigue were indicated by a score
of ≥22 [25].
Colorectal cancer-specific symptoms and two functioning
scales were measured with the EORTCQLQ-CR38 [26]. This
questionnaire consists of 38 items and contains the following
symptom scales: micturition problems, chemotherapy side ef-
fects, gastro-intestinal problems, defecation problems, having
a stoma and stoma-related problems, weight loss, and two
functioning scales: body image and future perspective. Scores
for scales and items from the EORTC QLQ-C30 and EORTC
QLQ-CR38 were linearly transformed to a 0 to 100 scale
according to the guidelines [26]. High functioning scores in-
dicate better functioning, while high symptom scores indicate
higher symptom burden.
Statistical analyses
Differences in socio-demographic and clinical characteristics
between respondents, non-respondents, and patients with un-
verifiable addresses, and between patients who completed
one and those who completed more than one questionnaire
were compared with a chi-square or ANOVA where appro-
priate to assess the representativeness of the sample. Slopes
were made of MVPA over time for nine independent vari-
ables to investigate the change in MVPA over time for par-
ticipants who completed all three questionnaires. Further
analyses were based upon all participants and included all
variables. Outliers of MVPA (>95th percentile) were imputed
by the 95th percentile value. Missing items from multi-item
scales were imputed according to the questionnaire guidelines
[20, 21, 23, 24, 27].
The first part of the analyses included longitudinal data
analyses. The individual association between each indepen-
dent variable (Table 1) and MVPA over time was analyzed
by using linear-mixed models. Linear-mixed models were
used to adjust for the dependence of observations. Continuous
independent variables were grand-mean centered to reduce
Support Care Cancer
multicollinearity. In the first step, we developed a longitudinal
model, using linear-mixed models, by putting MVPA as de-
pendent variable in the regression equation and one variable of
interest, two dummies for time (T2 vs. T1 and T3 vs. T1) and
the possible confounders as independent variables. A priori
chosen possible confounders were the following: age, gender,
having a partner, educational level, years since diagnosis, tu-
mor stage, number of comorbidities, and BMI.
In the second step of the longitudinal data analyses,
we examined the between-subject and within-subject ef-
fect for each continuous independent variable separately.
The between-subject estimate was used to see if differ-
ences in the independent variable between participants
resulted in differences in MVPA and was represented
by a participants’ average amount of MVPA reported
during the study across the three measurements. The













Male 1339 (54.6) 275 (47.7) 148 (48.4)
Female 1112 (45.4) 301 (52.3) 158 (51.6)
Age at time of survey: mean (SD) 69.6 (9.5) 72.8 (9.4) 68.9 (12.4) <0.01
<55 years 186 (7.6) 31 (5.4) 42 (13.7) <0.01
55–74 years 1470 (60.0) 267 (46.4) 144 (47.1)
≥75 years 795 (32.4) 278 (48.3) 120 (39.2)






Years since diagnosis/mean (SD) 5.3 (2.8) 5.3 (2.9) 5.7 (2.9) 0.02
Localization 0.02
Colon cancer 1510 (61.6) 390 (67.7) 191 (62.4)
Rectal cancer 941 (38.4) 186 (32.3) 115 (37.6)
Tumor stage 0.05
I 780 (31.8) 156 (27.1) 91 (29.7)
II 947 (38.6) 258 (44.8) 132 (43.1)
III 724 (29.5) 162 (28.1) 83 (27.1)
Treatment <0.01
Surgery only 1215 (49.6) 343 (59.6) 176 (57.9)
Surgery and RT 565 (23.1) 95 (16.5) 52 (17.1)
Surgery and CT 497 (20.3) 97 (16.8) 51 (16.8)
Surgery, RT and CT 171 (7.0) 38 (6.6) 23 (7.6)
Comorbidities
No comorbidities 673 (25.0)
1 comorbid condition 659 (28.8)
2 or more comorbid conditions 1060 (46.3)




RT radiotherapy, CT chemotherapy, BMI body mass index
a Educational level: High University or high education, Medium Vocational training, Low secondary, primary or less
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within-subject estimate was used to study potential caus-
al relations, by assessing if changes in the independent
variable within a participant were related to changes in
MVPA and was represented by the difference between a
participants’ MVPA at a certain point in time and his/her
average MVPA during the study. The between-subject
and within-subject estimates were simultaneously entered
in the linear-mixed models together with the possible
confounders and two dummies for time. Statistically
(non-)significant beta’s for the between-subject and
within-subject estimates were presented for the clinical
important difference (CID) in scale scores of the inde-
pendent variables, based on the guidelines for interpreta-
tion of the EORTC QLQ-C30 [28]. The CID in EORTC
QLQ-CR38, FAS, and HADS scores was obtained by
Norman’s Brule of thumb,^ whereby a ±0.5 SD differ-
ence in scores indicates a threshold for discriminating
change in HRQoL scores of a chronic illness [29]. In
the third step of the longitudinal data analyses, we in-
cluded an interaction term to investigate if associations
with MVPA were different for CRC survivors with stage
I, II, or III. Due to these different treatments, i.e., surgery
or adjuvant chemotherapy, CRC survivors may have dif-
ferent symptoms which influenced MVPA.
The second part of the analyses included cross-
sectional data analyses, using multiple linear regression
techniques to assess the conjoint association between
multiple independent variables and MVPA at T1. The
explained variance at T1 was assessed for the following
domains: socio-demographic factors, clinical factors, psy-
chological barriers, all functional-related barriers, and all
symptom-related barriers. Linear regression analyses
were more appropriate than linear-mixed models to as-
sess the explained variance and therefore, we examined
the conjoint association at a time point instead of over
time. All statistical analyses were conducted using SAS
version 9.3 (Statistical Analysis System); p values of
<0.01 were considered statistically significant as multiple
associations were tested.
Results
Characteristics of respondents and non-respondents
At T1, the response rate was 74% (N=2451), 47% (N=1547)
completed the questionnaire at T2, and 41 % (N=1375) at T3.
Respondents were 69.6 (SD=9.5) years, 55 % were male and
years since diagnosis was on average 5.3 (SD=2.8) and there
were minimal 1.4 year since diagnosis at T1. Respon-
dents were 3 years younger, more often male, and
underwent more often surgery only compared with non-
respondents (all p<0.01; Table 2).
CRC survivors who completed only one questionnaire
were older at time of first enrollment (71.4 vs. 68.4;
p<0.01), were more often female (49 vs. 43 %; p=0.01) and
had a lower educational level (27 vs. 17%; p<0.01) compared
with CRC survivors who completed more then one question-
naire. No differences were found in years since diagnosis,
BMI, and number of comorbid conditions. Furthermore,
CRC survivors who completed only one questionnaire often
did not meet the guidelines of MVPA (25 vs. 10 %; p<0.01)
and spent on average less hours per week on MVPA (9.1 vs.
12.0 h/week; p<0.01).
Socio-demographic and clinical factors and MVPA
Levels of MVPA were relatively stable over time; however,
they were different between male and female CRC survivors
(Fig. 1). Male survivors reported, on average, 1.90 h/week
more MVPA than female survivors over time (Table 3). Fur-
thermore, survivors who were 55–74 years old reported 3.34
(p<0.01)h/week more MVPA then survivors who were
≥75 years old. CRC survivors who had a partner reported
1.11 (p<0.01)h/week more MVPA than CRC survivors with-
out a partner. Other significant differences inMVPA over time
were found for normal weight vs. obesity (B=2.38) and over-
weight vs. obesity (B=1.67) (Table 3). In addition, no associ-
ations were found for having a stoma, educational level, years
since diagnosis, treatment, localization of cancer, and number
of comorbidities.
Psychological barriers and MVPA
Figure 1 shows that the levels of MVPAwere relatively stable
over time; however, they were different between CRC survi-
vors who were anxious or reported depressive symptoms and
their counterparts. Furthermore, statistically significant
between-subject estimates were found for anxiety (B=−0.29)
and depressive symptoms (B=−0.73), meaning that a 1.8
point (±0.5 SD) higher score on these scales compared with
another participant was associated with 0.29 or 0.73 h/week
less MVPA (Table 3).
Functioning-related barriers and MVPA
Statistically significant differences were found for physical
functioning (B=0.66; between-subject estimate), meaning that
a 5-point higher score on this scale compared with another
participant was associated with 0.66 h/week more MVPA.
Other significant differences were found for role functioning
(B=0.38), future perspective, and global quality of life (all
between-subject estimates, Table 3).
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Symptom-related barriers and MVPA
Levels of MVPA were lower for CRC survivors who were
fatigued vs. those who were not fatigued or reported above vs.
below average scores on the dyspnea scale during thewhole study
(Fig. 1). Furthermore, statistically significant differences were
found for fatigue (B=−0.79; between-subject estimate) meaning
that a 3.4 point (±0.5 SD) higher score on this scale compared
with another participant was associated with 0.79 h/week less
MVPA. Other significant results were found for chemotherapy
side effects, micturition problems, appetite loss, weight loss,
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Stable global quality of life >
mean (N=496)
Fluctuang (N=522)
Stable global quality of life ≤ 
mean (N=256)
MVPA (hrs./week)
Fig. 1 Longitudinal changes in mean score ofMVPA (h/week) over time
for gender, having a stoma, BMI, fatigue, anxiety, depressive symptoms,
physical functioning, global quality of life, and dyspnea among
participants who completed all three questionnaires (N=1274). MVPA
moderate-to-vigorous physical activity. Higher mean scores of physical
functioning and global quality of life implicate better functioning, where-
as higher mean scores of dyspnea indicate a higher symptom burden
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Table 3 Adjusted linear-mixedmodels estimating the individual associations between each independent factor andMVPA (h/week) over time (T1N=
2451; T2 N=1547; T3 N=1375)
Number in analysis* CID B** 95 % CI Lower limit 95 % CI Upper limit p value
Socio-demographic factors
Gender (male vs. female) 4768 1.90 1.23 2.58 <0.01
Age 4768
<55 vs. ≥75 years 1.10 −0.22 2.20 0.08
55–74 vs. ≥75 years 3.34 2.73 4.04 <0.01
Partner (yes vs. no) 4768 1.11 0.36 1.87 <0.01
Educational levela 4768
Low vs. high −0.19 −1.01 0.64 0.65
Medium vs. high 0.65 −0.02 1.59 0.06
Medium vs. low 0.97 0.35 1.60 <0.01
Clinical factors
Years since diagnosis 4768 0.05 −0.05 0.17 0.37
Colon vs. rectal cancer 4768 0.37 −0.30 1.04 0.28
Tumor stage 4768
II vs. I −1.11 −1.88 −0.34 <0.01
III vs. I −0.58 −1.40 0.23 0.16
Treatment 4926
Surgery + CT + RT vs. surgery only −0.79 −2.13 0.54 0.24
Surgery and RT vs. surgery only −0.31 −1.12 0.49 0.44
Surgery and CT vs. surgery only 0.58 −0.46 1.62 0.27
CT vs. RTb 2482 0.37 −0.76 1.49 0.52
Stoma (yes vs. no) 2874 −1.24 −2.10 −0.38 <0.01
Comorbidities 4768
No vs. ≥2 comorbid conditions 0.70 0.03 1.36 0.04
1 vs. ≥2 comorbid conditions 0.49 −0.07 1.05 0.09
BMI 4726
Normal weight vs. obesity 2.38 1.51 3.24 <0.01
Overweight vs. obesity 1.67 0.89 2.44 <0.01
Symptom-related barriersc
Fatigue Between 4698 3.4 −0.79 −0.96 −0.61 <0.01
Within 3.4 −0.25 −0.50 0.01 0.05
Pain Between 4742 6 −0.22 −0.32 −0.13 <0.01
Within 6 0.01 −0.08 0.11 0.75
Nausea Between 4725 3 −0.15 −0.25 −0.05 <0.01
Within 3 −0.08 −0.16 −0.01 0.05
Dyspnea Between 4698 4 −0.21 −0.27 −0.15 <0.01
Within 4 −0.04 −0.11 0.03 0.24
Insomnia Between 4715 4 −0.07 −0.13 −0.02 <0.01
Within 4 −0.03 −0.09 0.02 0.28
Appetite loss Between 4720 5 −0.29 −0.40 −0.17 <0.01
Within 5 −0.08 −0.18 0.03 0.14
Financial difficulties Between 4706 3 −0.08 −0.14 −0.02 <0.01
Within 3 −0.01 −0.05 0.07 0.81
Micturition problems Between 4669 8.7 −0.39 −0.57 −0.20 <0.01
Within 8.7 −0.03 −0.22 0.16 0.76
Chemo side effects Between 4693 7.9 −0.41 −0.60 −0.22 <0.01
Within 7.9 −0.04 −0.23 0.14 0.65
Gastro-intestinal problems Between 4655 7.2 −0.12 −0.30 0.06 0.20
Support Care Cancer
An interaction term was added to investigate if associations
withMVPAwere different for CRC survivors with stage I, II, or
III. Solely, the interaction term for cognitive functioning was
significant (p<0.01). Subgroup analysis demonstrated that
there was a significant association between cognitive function-
ing and MVPA for stage I survivors (B=0.06; between-subject
estimate), whereas not for stage II and III survivors.
Conjoint associations with MVPA
At T1, 10.6 % of the differences in MVPA could be explained
by differences in functioning-related barriers (Table 4). Differ-
ences in functioning-related barriers could explain the highest
variance in MVPA compared with other groups of factors. Of
the functioning-related barriers, physical functioning
Table 3 (continued)
Number in analysis* CID B** 95 % CI Lower limit 95 % CI Upper limit p value
Within 7.2 −0.03 −0.18 0.23 0.80
Defecation problems Between 3609 6.0 −0.21 −0.41 −0.01 0.04
Within 6.0 −0.03 −0.27 0.22 0.83
Stoma-related problems Between 967d 10.4 −0.04 −0.41 0.34 0.85
Within 10.4 −0.10 −0.45 0.65 0.71
Weight loss Between 4716 7.8 −0.26 −0.46 −0.07 <0.01
Within 7.8 −0.12 −0.27 0.02 0.09
Functioning-related barrierse
Physical functioning Between 4741 5 0.66 0.58 0.75 <0.01
Within 5 0.10 −0.03 0.24 0.13
Role functioning Between 4726 6 0.38 0.29 0.46 <0.01
Within 6 0.04 −0.05 0.12 0.41
Social functioning Between 4721 5 0.26 0.18 0.35 <0.01
Within 5 0.05 −0.04 0.13 0.29
Emotional functioning Between 4722 4 0.20 0.13 0.28 <0.01
Within 4 0.01 −0.09 0.08 0.93
Cognitive functioning Between 4728 3 0.09 0.04 0.15 <0.01
Within 3 0.06 0.00 0.12 0.07
Global quality of life Between 4739 4 0.37 0.29 0.45 <0.01
Within 4 0.02 −0.06 0.11 0.57
Body image Between 4692 10.9 0.19 0.01 0.36 0.03
Within 10.9 0.02 −0.23 0.18 0.82
Future perspective Between 4728 13.7 0.38 0.20 0.57 <0.01
Within 13.7 0.02 −0.20 0.17 0.87
Psychological barriers
Anxiety Between 4685 1.8 −0.29 −0.46 −0.12 <0.01
Within 1.8 −0.08 −0.31 0.15 0.51
Depressive symptoms Between 4704 1.8 −0.73 −0.90 −0.55 <0.01
Within 1.8 −0.21 −0.45 0.03 0.09
Linear-mixed models are adjusted for gender, age, educational level, having a partner, years since diagnosis, tumor stage, number of comorbidities, and
BMI
MVPA moderate-to-vigorous physical activity; CID clinical important difference in scores of the scales and items of the EORTC QLQ-C30, EORTC
QLQ-CR38, FAS, and HADS; CI confidence interval; CT chemotherapy; RT radiotherapy
a Educational level: High university or high education, Medium vocational training, Low secondary, primary or less
b Patients underwent surgery as primary treatment
c Higher scores implicate higher symptom burden
dOnly patients with a stoma were asked to fill in items concerning stoma-related problems
eHigher scores implicate better functioning
*Each row in the analyses represents a patient at one time point, resulting in a maximum of three rows per patient in a long data file used for the linear-
mixed models
**B is calculated for the clinical important difference (CID) in scale scores of the independent variables
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explained the highest variance in MVPA. Differences in
symptom-related barriers explained 3.8 % of the differences
in MVPA and most variance could be attributed to differences
in fatigue, dyspnea, and chemotherapy side effects. Because
of the large number of variables and some variables being
correlated, we could not include all variables of interest in
one linear regression analysis to assess the explained variance.
Therefore, we decided to analyze groups of related barriers to
assess explained variance per group. As a consequence, these
explained variances cannot be summed, since they could have
overlapping variance.
Discussion
This longitudinal population-based cohort study examined the
individual and conjoint association of factors with physical
activity among CRC survivors. According to our results, sev-
eral factors were negatively associated with physical activity
over time: symptom-related barriers (e.g., fatigue, dyspnea,
chemotherapy side effects, pain, appetite loss, and weight
loss); psychological barriers (i.e., depressive symptoms and
anxiety); functioning-related barriers (e.g., low physical or
role functioning, unfavorable future perspective, low global
quality of life); socio-demographic (i.e., being ≥75 years old,
being female, having no partner); and clinical factors (i.e.,
being overweight or obese). Furthermore, conjoint associa-
tions indicated that most differences in physical activity can
be attributed to differences in functioning aspects and experi-
enced symptoms of cancer and its treatment.
Our results regarding individual associations with physical
activity are in line with previous studies. Courneya et al. [11]
found that fatigue was an important barrier for physical activ-
ity among CRC survivors. Furthermore, previous studies have
also found that being female, having a higher BMI and being
anxious were associated with a lower physical activity among
CRC survivors [10, 15]. In contrast with previous studies, in
the present study, the number of comorbidities and tumor
stage were not significantly associated with physical activity
[10, 12].
In the present study, conjoint associations demonstrated
that differences in functioning-related barriers and symptom-
related barriers seem to be important in explaining differences
in MVPA, whereas socio-demographic and clinical factors
seem to be less important. These results are in accordancewith
results of Lynch et al. [13], who found that disease-specific
side effects are perceived as the greatest barriers to physical
activity for CRC survivors.
A few results require further explanation. Besides signifi-
cant between-subject effects, no within-subject effects were
significant which indicates that the factors included in the
analyses were significantly associated with MVPA over time
between respondents but not within respondents. This could
be caused by the fact that factors assumed to be related
with MVPA were relatively stable over time within partic-
ipants, which could be related to the fact that respondents
were, on average, 5 years after diagnosis. Second, there
was no association between having a stoma or stoma-
related problems and MVPA. An explanation could be
that the severity of stoma-related problems was generally
low among the CRC survivors with a stoma in the present
study and therefore may not affect MVPA. The low sever-
ity of stoma-related problems reported by CRC survivors
with a stoma could be explained by the high number of
long-term survivors (more than 5 years after diagnosis)
and a decrease of stoma-related problems over time [13,
30, 31]. Third, our results demonstrated that survivors
who were 55–74 years old were more physically active
then survivors who were <55 years old. This relatively
high level of physical activity among survivors who were
55–74 years old could be caused by early retirement or
not having a paid job at the time of study whereby pa-
tients have more leisure time to be physically active [32].
Finally, this study showed that survivors who had surgery
and chemotherapy were more physically active then sur-
vivors who only had surgery. An explanation could be
that patients who were treated with chemotherapy re-
ceived more advice on the health benefits of physical
activity from health care professionals [33].
Besides socio-demographic factors, clinical factors, and
perceived barriers, other behavioral factors could also affect
physical activity among CRC survivors [9]. Such behavioral
factors could be the intention to be physically active, the sub-
jective norm (a person’s own estimate of the social pressure to
be physically active), the instrumental attitude (the expected
benefits of being physical active), and the affective attitude
(the expected enjoyment of being physical active) [34, 35].
Furthermore, lack of time or enjoyment; facilities to be phys-
ically active; encouragement from family, friends, and health
Table 4 Linear regression techniques estimating the explained variance
for groups of factors in MVPA at T1
Domains Numbera R2
Socio-demographic factors 2407 0.039
Clinical factors 2061 0.022
Symptom-related barriersb 1680 0.038
Functioning-related barriersc 2340 0.106
Psychological barriers 2345 0.024
MVPA moderate-to-vigorous physical activity, R2 explained variance
a Number of patients included in the analysis
bR2 of all symptom-related scales in one model (EORTC QLQ-30,
EORTC QLQ-CR38, and FAS)
cR2 of all functioning scales and global quality of life in one model
(EORTC QLQ-30 and EORTC QLQ-CR38)
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professionals could affect physical activity [13]. Future re-
search should assess these factors and relate them to important
correlates found in the present study.
Response rates decreased during the present study because
respondents stopped participating or deceased. The decrease
in response rates may have influenced the results. Respon-
dents who completed only one questionnaire were less phys-
ically active compared with patients who completed two or
three questionnaires which may led to an overestimation of
MVPA at T2 and T3. Due to selection bias, respondents may
be a more homogenous group than the target population,
which could lead to underestimations of the effect estimates.
However, this should not affect the direction of the associa-
tions. Incentives might have improved the compliance [36].
The current study has some limitations. There were differ-
ences between respondents and non-respondents, which may
decrease the generalizability of our results. Furthermore, this
study presented statistically significant results, whereas it was
not possible to present clinically relevant results because no
guidelines were available for the minimal clinically significant
difference in MVPA. Another limitation is the use of self-
report measures to assess MVPA. This may have led to sys-
tematic overestimation of MVPA levels [37]. Nevertheless,
this study is one of the few available studies that reported a
comprehensive view on factors associated with physical ac-
tivity among CRC survivors. Moreover, this study is a large
longitudinal population-based cohort study.
In conclusion, multiple individual factors from all domains
were negatively associated with physical activity over time
among CRC survivors. However, barriers and MVPA were
relatively stable over time and therefore, this study found no
association between changes in barriers and changes in
MVPA (within-subject effects). Furthermore, conjoint associ-
ations indicated that most differences in physical activity can
be attributed to differences in functioning aspects and experi-
enced symptoms of cancer and its treatment. Future interven-
tions to increase physical activity levels among CRC survi-
vors should take into account functioning aspects and symp-
toms of cancer and its treatment.
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